Valuation check: HYPMY's P/E ratio is 8.03, below the Healthcare sector average of 26.36.
Get informed when a big investor buys or sells
+ Follow8.03
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Hypera S.A. (HYPMY) currently reports a P/E ratio of 8.03. That is below the Healthcare sector average of 26.36. Use the charts on this page to explore Hypera S.A.'s P/E ratio history and peer comparisons.
Hypera S.A.'s P/E ratio of 8.03 is lower than the Healthcare sector average of 26.36. That is roughly 69.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates Hypera S.A.'s market price to a fundamental measure such as earnings, sales, or book value. At 8.03, HYPMY can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of 8.03, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 26.36. From there, open related valuation or income-statement pages for Hypera S.A., and consider following HYPMY for alerts when major investors trade the stock.
Hypera S.A. is classified in the Healthcare sector. On P/E ratio, it currently shows 8.03 versus a sector average near 26.36. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HYPMY with unrelated industries.